XML 57 R48.htm IDEA: XBRL DOCUMENT v3.22.2
Non-Consolidated Affiliates (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Feb. 11, 2020
Schedule of Equity Method Investments [Line Items]            
Equity method investments $ 412,076   $ 412,076   $ 435,394  
Equity in income (loss) of non-consolidated affiliates 737 $ 17,701 1,134 $ 15,783    
Distributions from equity method investees     0 523    
Distributions from equity method investees     27,502 22,003    
Legacy Investors Partnerships            
Schedule of Equity Method Investments [Line Items]            
Equity method investments           $ 303,700
Equity in income (loss) of non-consolidated affiliates 4,700 25,600 9,300 30,800    
Distributions from equity method investees 6,800 4,700 14,100 8,600    
Avillion Entities            
Schedule of Equity Method Investments [Line Items]            
Equity in income (loss) of non-consolidated affiliates (4,000) $ (7,900) (8,200) (15,000)    
Equity method investment, unfunded commitments (35,700)   (35,700)   $ (11,200)  
Avillion I            
Schedule of Equity Method Investments [Line Items]            
Distributions from equity method investees     13,400 $ 13,400    
Avillion II | Merck Asset - Phase II Clinical Trial            
Schedule of Equity Method Investments [Line Items]            
Other commitment 150,000   150,000      
Increase in commitment $ 27,500   $ 27,500